Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07307339

The Acute Effects of Blood Flow Restriction on Ankle Muscle Reaction Time and Proprioception in Healthy Individuals

his randomized controlled crossover study aims to investigate the acute effects of lower limb blood flow restriction (BFR) on ankle joint proprioception, postural control, and muscle activation in healthy adults. Each participant will complete test sessions under BFR (60% individualized arterial occlusion pressure) and control (20 mmHg sham) conditions. Outcome measures include joint position sense, kinesthesia, static and dynamic balance performance, and electromyographic (EMG) activity and reaction times of selected lower limb tibialis anterior and peroneus longus muscles.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

18 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Uludag University

Bursa, 16059, Turkey (Türkiye)

About this study

Lateral ankle sprains are among the most common musculoskeletal injuries and may lead to chronic ankle instability (CAI), partly due to impaired proprioception and neuromuscular control. Blood flow restriction (BFR) training is widely used to augment muscular adaptations with low external loads; however, its acute effects on joint proprioception and sensorimotor control, particularly at the ankle joint, remain unclear and may be detrimental under certain conditions. This randomized controlled crossover trial will examine the effects of a single-session lower limb BFR application on ankle joint position sense, kinesthesia, static and dynamic balance, and EMG-based reaction time and activity of lower limb muscles in healthy adults. Participants aged 18-40 years without recent ankle sprain, neuromuscular, cardiovascular, or thromboembolic disease will undergo standardized proprioception tests using an isokinetic dynamometer, static balance tests on a force platform, Y-balance test, and inversion simulation platform assessments under BFR (60% arterial occlusion pressure) and low-pressure control (20 mmHg) conditions. Individual arterial occlusion pressure (AOP) will be determined using Doppler ultrasound, and BFR will be applied with a pneumatic cuff at the most proximal thigh. All measurements will be performed on the dominant lower limb with sessions scheduled at the same time of day to minimize circadian variability. The primary hypothesis is that acute lower limb BFR will worsen ankle joint proprioception and sensorimotor control compared with the control condition, potentially indicating a transient increase in injury risk during BFR-assisted activities.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged between 18 and 40 years
  • No known neuromuscular or cardiovascular disease

Exclusion criteria

  • History or presence of cardiac, coronary artery, or peripheral arterial disease
  • Presence or history of varicose veins, hypertension, diabetes mellitus, or pulmonary disease
  • History of pulmonary embolism or deep vein thrombosis
  • Use of medications affecting the central nervous or cardiovascular systems
  • Use of oral contraceptives or anticoagulants
  • Pregnancy
  • Open wounds or significant scar tissue at the cuff application site
  • History of lower extremity musculoskeletal injury or surgery
  • Any neurological, vascular, or systemic condition that may interfere with test performance

Treatment and study plan

Blood Flow Restriction

Other

Arm Description: Participants perform balance/proprioception tests under lower limb blood flow restriction at % 60 AOP.

Sham Blood Flow Restriction

Other

Sham BFR Description: Participants perform the same tests with sham(20 mmHg) blood flow restriction

Primary outcomes

  1. Change in Ankle Joint Position Sense Error (degrees)

    Time frame: day 1 and day 2

    Absolute error (degrees) between target and reproduced angles during passive and active joint position sense tests in inversion and plantar flexion, measured with an isokinetic dynamometer.

  2. Static Balance Performance

    Time frame: day 3

    Center of pressure path length (mm) in single-leg and tandem stance with eyes open/closed on force platform (HUR SmartBalance).

  3. Change in Kinesthesia Threshold (degrees)

    Time frame: day 1 and day 2

    Minimal angular displacement (degrees) at which movement is first perceived in inversion and plantarflexion.

  4. Static balance performance

    Time frame: day 3

    sway velocity (mm/s) in single-leg and tandem stance with eyes open/closed on force platform (HUR SmartBalance).

  5. static balance performance

    Time frame: day 3

    sway area (mm^2) in single-leg and tandem stance with eyes open/closed on force platform (HUR SmartBalance).

Secondary outcomes

  1. Y-Balance Test Reach Distances (cm)

    Time frame: day 4

    Anterior, posteromedial and posterolateral reach distances of the tested limb.

  2. Peroneus Longus and Tibialis Anterior Reaction Time (ms)

    Time frame: day 4

    Time from onset of platform-induced inversion to EMG activation exceeding 2× resting activity.

  3. Lower Limb EMG Activity (%MVIC)

    Time frame: day 4

    Mean EMG amplitude normalized to maximal voluntary isometric contraction values.

Sponsors and collaborators

Lead sponsor

Uludag University

Other

Registry information

Important dates

Study start
2025
Primary completion
2025
Study completion
2026
First posted
Dec 29, 2025
Registry last updated
Dec 29, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.